Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey

Annales de Medecine Interne

Volumn 153, Issue 7 SUPPL. 1, 2002, Pages

  Fischer, Benedikt ^a   Cape, Deana ^a   Daniel, Natalie ^a   Gliksman, Louis ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Methadone treatment; Survey

Indexed keywords

METHADONE; OPIATE;

ABSTINENCE; ARTICLE; CANADA; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENERAL PRACTITIONER; GEOGRAPHY; HAZARD; HEALTH SURVEY; HUMAN; LEGAL ASPECT; MALE; MEDICAL PRACTICE; METHADONE TREATMENT; NORMAL HUMAN; OPIATE ADDICTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; WORKLOAD;

DRUG UTILIZATION; HUMANS; METHADONE; NARCOTICS; ONTARIO; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 0036868225     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Institute of Medicine. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press, 1995.
2. nd Ed. Philadelphia: Williams and Wilkins, 1992.
3. Farrell M, Ward J, Mattick R, Hall W, Stimson G, Des Jarlais D, et al. Methadone maintenance treatment in opiate dependence: A review. Br Med J, 1994; 309: 997-1001.
4. National Institutes of Health. National consensus development panel on effective medical treatment of opiate addiction. JAMA, 1998; 280: 1936-43.
5. Bertschy G. Methadone maintenance treatment: An update. Eur Arch Psychiatry Clin Neurosci, 1995; 245: 114-24.
6. Ward J, Hall W, Mattick R. Role of methadone maintenance in opioid dependence. Lancet, 1999; 353: 221-6.
7. Ball J, Ross A. The Effectiveness of Methadone Maintenance of Treatment: Patients, Programs, Services and Outcomes. New York: Springer-Verlag, 1991.
8. Rosenbaum M. The demedicalization of methadone maintenance. In: Erickson PG, Riley D, Cheung Y, O'Hare W, O'Hare P, eds. Harm Reduction: A New Direction for Drug Policies and Programs. Toronto: University of Toronto Press, 1997: 69-79.
9. Courtwright D. A century of american narcotic policy. In: Gerstein D, Harwood H, eds. Treating Drug Problems. Vol. 2. Washington, DC: National Academy Press, 1992.
10. Fischer B. Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. J Public Health Policy, 2000; 21: 187-210.
11. Farrell M, et al. A Review of the Legislation, Regulation and Delivery of Methadone in 12 Member States of the European Union. Final Report of the National Addiction Centre. London, 1995.
12. Swiss Federal Office of Public Health. Swiss Methadone Report. Berne/Toronto: Swiss Federal Office of Public Health/Addiction Research Foundation, 1996.
13. Nadelmann E, McNeely J. Doing methadone right. The Public Interest, 1996; 123: 83-93.
14. Strang J, Sheridan J. Heroin prescribing in the "British System" of the mid 1990s: Data from the 1995 national survey of community pharmacies in England and Wales. Drug Alcohol Rev, 1997; 16: 7-16.
15. Stimson G, Lart R. The relationship between the State and local practice in the development of national policy on drugs between 1920 and 1990. In: Strang J, Gossop M, eds. Heroin Addiction and Drug Policy: The British System. Oxford: Oxford University Press, 1994: 331-41.
16. Fleming P, Morey J, Charlton P. Is the policy of encouraging general practitioners to prescribe opiates flawed? Int J Drug Policy, 1997; 8: 172-7.
17. Marsden J, Gossop M, Farrell M, Strang J. Opioid substitution: Critical issues and future directions. J Drug Issues, 1998; 28: 243-64.
18. Fischer B, Medved W, Rehm J, Gilksman L. Profile of illicit and un-treated opiate users in Toronto, Canada. Addict Res, 1999; 7: 377-415.
19. Nadelmann E, McNeely J, Drucker E. Harm reduction drug control strategies: A global perspective. In: Lowinson J, Ruiz P, Millman R, eds. Substance Abuse: A Comprehensive Textbook. Baltimore: Williams and Wilkins, 1997.
20. Commonwealth Department of Human Services and Health. Review of Methadone Treatment in Australia. Final Report. Australia, 1995.
21. Byrne A, Wodak A. Census of patients receiving methadone treatment in a general practice. Addict Res, 1996; 3: 341-9.
22. Wilson P, Watson R, Ralston G. Methadone maintenance in general practice: Patients, workload, and outcomes. Br Med J, 1994; 309: 641-4.
23. Brussel GV. Methadone treatment in Amsterdam: The critical role of general practitioners. Addict Res, 1996; 3: 363-8.
24. Newman R. Another wall that crumbled: Methadone maintenance treatment in Germany. Am J Drug Alcohol Abuse, 1995; 21: 27-35.
25. Kalke J, Verthein U, Raschke P. 10-Jahre substitutions-therapie in der bundesrepublik deutschland - Politische entwicklung und evaluationsergebnisse. Wiener Zeitschrifi für Suchtforschung, 1998; 21: 47-54.
26. Caplehorn JRM. A comparision of private and public methadone maintenance patients. Drug Alcohol Rev, 1992; 11: 43-9.
27. Richards T. Drug addicts and the GP. Br Med J, 1988; 296: 755-8.
28. Greenwood J. Presuading general practitioners to prescribe-good husbandry or a recipe for chaos? Br J Addict, 1992; 87: 567-75.
29. Bell J. Alternatives to non-clinical regulation: Training doctors to deliver methadone maintenance treatment. Addict Res, 1996; 3: 315-22.
30. Martin E. Training in substance abuse is lacking for GPs. Br Med J, 1996; 312: 186.
31. Hannifin J. Methadone maintenance treatment in New Zealand: Back to the future? J Maintenance Addict, 1997; 1: 69-80.
32. Bossong H. Methadone-substitutionsbehandlung. Das Gruene Gehirn-Der Arzt im Offentlichen Gesundheitswesen, 1995: 36: Erg.
33. Senay E, Uchtenhagen A. Methadone in the treatment of opiod dependence: A review of the world literature. In: Arif A, Westermeyer J, eds. Methadone Maintenance in the Management of Opioid Dependence. New York: Praeger, 1990.
34. Bell J, Chan J, Kuk A. Research report: Investigating the influence of treatment philosophy on outcome of methadone maintenance. Addiction, 1995; 90: 823-30.
35. Paulus I, Halliday R. Rehabilitation and the narcotic addict: Results of a comparative methadone withdrawal program. Can Med Assoc J, 1967; 96: 655-9.
36. Giffen JP, Endicott S, Lambert S. Panic and Indifference. The Politics of Canada's Drug Laws. Ottawa: Canadian Centre on Substance Abuse, 1991.
37. Ferguson J, Ettinger G, Joron G, Lederman J, Mac-Kenzie D. Good medical practice in the care of the narcotic addict. A report prepared by a Special Committee appointed by the Executive Committee of the Canadian Medical Association. Canadian Med Assoc J, 1965; 92: 1040-3.
38. Ledain Commission. Commission of Inquiry Into the Non-Medical Use of Drugs. Treatment report. Ottawa: Information Canada, 1972.
39. Ledain Commission. Commission of Inquiry into the Non-Medical Use of Drugs. Treatment Report. Ottawa: Information Canada, 1973.
40. Fischer B, Rehm J. The case of the heroin substitution treatment trial in Canada. Can J Public Health, 1997; 88: 367-70.
41. Bishop JW. Methadone and the care of the narcotic addict. Report of a Special Joint Committee of CMA and the DNHW Food and Drug Directorate. Can Med Assoc J, 1971; 105: 1193-201.
42. Peachey JE, Franklin T. Methadone treatment of opiate dependence in Canada. Br J Addict, 1985; 80: 291-9.
43. Alexander BK, Millard CJ, Webster CD. Heroin 'treatment'in British Columbia, 1976-1984: Thesis, antithesis, and synthesis? Can J Criminol, 1987; 27: 195-208.
44. Brands J, Brands B, Marsh D. The expansion of methadone prescribing in Ontario, 1996-1997. Addict Res, 2000; 8: 485-96.
45. The College of Physicians and Surgeons in Ontario. Methadone Maintenance Guidelines. Toronto: The College of Physicians and Surgeons in Ontario, 1996.
46. Burr S (Director, Training and Professional Enhancement; College of Physicians and Surgeons of Ontario). Personal communication with Doug Gourlay. Addiction Research Foundation, March 27, 1998.